Skip to main content
. Author manuscript; available in PMC: 2015 Mar 3.
Published in final edited form as: J Virol Methods. 2011 Aug 5;177(2):168–173. doi: 10.1016/j.jviromet.2011.08.002

Table 1.

Primers/probes and optimal concentrations.

Serotype Primer/probe sequences (5′–3′) Position Final conc. (μM/reaction)
DENV-1-F ATCCATGCCCAYCACCAAT 9865–9883 1
DENV-1-R TGTGGGTTTTGTCCTCCATC 9945–9964 1
DENV-1-Probe FAM-TCAGTGTGGAATAGGGTTTGGATAGAGGAA-BHQ1 9907–9936 0.14
DENV-2-F TCCATACACGCCAAACATGAA 9859–9879 1
DENV-2-R GGGATTTCCTCCCATGATTCC 9963–9983 1
DENV-2-Probe FAM-AGGGTGTGGATTCGAGAAAACCCATGG-BHQ1 9916–9942 0.14
DENV-3-F TTTCTGCTCCCACCACTTTC 9591–9610 1
DENV-3-R CCATCCYGCTCCTTGAGA 9691–9708 1
DENV-3-Probe Cyan500-AAGAAAGTTGGTAGTTCCCTGCAGACCCCA-BHQ1 9633–9662 0.14
DENV-4-F GYGTGGTGAAGCCYCTRGAT 9587–9607 1
DENV-4-R AGTGARCGGCCATCCTTCAT 9744–9764 1
DENV-4-Probe Cyan500-ACTTCCCTCCTCTTYTTGAACGACATGGGA-BHQ1 9490–9519 0.14
EAV-F CATCTCTTGCTTTGCTCCTTAG 1847–1868 0.2
EAV-R AGCCGCACCTTCACATTG 1980–1997 0.2
EAV-Probe Cy5-CGCGCTCGCTGTCAGAACAACATTATTGCCCACAGCGCG-BHQ3 1926–1964 0.08
HHS Vulnerability Disclosure